Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives an Average “Hold” Rating from Brokerages

Shares of Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get a rating) earned an average recommendation of “Hold” from the twelve brokerages that currently cover the business, reports MarketBeat Ratings. Seven analysts rated the stock with a hold recommendation and five gave the company a buy recommendation. The 12-month average target price among brokers who have reported on the stock in the past year is $15.85.

SBRA has been the subject of several recent research reports. Mizuho upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and reduced its target price for the stock from $16.00 to $15.00 in a Wednesday, May 25 report. StockNews.com launched coverage on Sabra Health Care REIT in a Thursday, March 31 report. They have set a “holding” rating on the stock. Barclays downgraded Sabra Health Care REIT from an “overweight” rating to an “equal weight” rating and reduced its target price for the stock from $16.00 to $14.00 in a Monday, April 18 report. Capital One Financial launched coverage on Sabra Health Care REIT in a Friday, June 3 report. They set an “equal weight” rating and a target price of $15.50 on the stock. Finally, Credit Suisse Group raised its price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “neutral” rating in a Monday, April 4 report.

Sabra Health Care REIT trades up 0.6%

Shares of SBRA opened at $14.74 on Friday. The company has a market capitalization of $3.40 billion, a P/E ratio of -30.08 and a beta of 1.33. Sabra Health Care REIT has a 12-month low of $11.44 and a 12-month high of $19.01. The company has a quick ratio of 3.60, a current ratio of 3.60 and a leverage ratio of 0.70. The stock’s fifty-day simple moving average is $14.00 and its 200-day simple moving average is $13.62.

Sabra Health Care REIT (NASDAQ: SBRA – Get a rating) last released its quarterly earnings data on Wednesday, May 4. The real estate investment trust reported earnings per share of $0.18 for the quarter, beating analysts’ consensus estimate of $0.17 by $0.01. Sabra Health Care REIT posted a negative return on equity of 3.15% and a negative net margin of 18.28%. In the same quarter last year, the company posted EPS of $0.39. As a group, sell-side analysts expect Sabra Health Care REIT to post 1.47 EPS for the current fiscal year.

Sabra Health Care REIT announces dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 31. Investors of record on Monday, May 16 received a dividend of $0.30 per share. This represents a dividend of $1.20 on an annualized basis and a yield of 8.14%. The ex-dividend date was Friday, May 13. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently -244.89%.

Institutional entries and exits

Institutional investors have recently increased or reduced their stake in the company. Wedbush Securities Inc. acquired a new position in Sabra Health Care REIT during Q1 worth approximately $740,000. Comerica Bank increased its stake in Sabra Health Care REIT by 7.8% during the 1st quarter. Comerica Bank now owns 280,321 shares of the real estate investment trust worth $3,509,000 after buying an additional 20,295 shares last quarter. Bank of America Corp DE increased its stake in Sabra Health Care REIT by 40.6% during the 4th quarter. Bank of America Corp DE now owns 335,561 shares of the real estate investment trust worth $4,543,000 after buying an additional 96,846 shares last quarter. Parallel Advisors LLC increased its stake in Sabra Health Care REIT by 255.1% during the 1st quarter. Parallel Advisors LLC now owns 10,181 shares of the real estate investment trust worth $152,000 after buying an additional 7,314 shares in the last quarter. Finally, the New Jersey State Joint Pension Fund D increased its stake in Sabra Health Care REIT by 10.3% during the 4th quarter. New Jersey State Joint Pension Fund D now owns 298,512 shares of the real estate investment trust worth $4,042,000 after purchasing an additional 27,980 shares in the last quarter. 91.61% of the shares are held by institutional investors and hedge funds.

Sabra Health Care REIT Company Profile

(Get a rating)

As of March 31, 2022, Sabra’s investment portfolio included 416 properties held for investment. These include (i) 279 skilled nursing/transitional care facilities, (ii) 59 senior housing communities (senior residences – leased), (iii) 50 senior housing communities operated by third-party property managers pursuant to property management agreements (retirement homes – managed), (iv) 13 behavioral health facilities and (v) 15 specialty hospitals and other facilities), an asset held for sale, an investment in a lease-purchase, 16 investments in loans receivable (including (i) two mortgage loans, (ii) a construction loan and (iii) 13 other loans), seven investments in preferred shares and an investment in a unconsolidated joint venture.

Recommended Stories

Analyst Recommendations for Sabra Health Care REIT (NASDAQ: SBRA)

This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes higher…and Sabra Health Care REIT was not on the list.

While Sabra Health Care REIT currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

About Erick Miles

Check Also

When will used car prices drop?

In KPMG’s recent report, they illustrate four scenarios for the market to return to more …